Apposite Capital

Apposite Capital operates as a specialist pan-European investor, providing dedicated capital to high-growth, high-impact opportunities within the healthcare sector. The firm's core product involves offering first institutional investment to European small and medium-sized enterprises (SMEs), utilizing deep thematic sector insights and an extensive network of healthcare leaders. Their strategic approach supports businesses in scaling through various mechanisms, including management buyouts, growth capital, and founder transitions, across areas like digital health, medical devices, and pharmaceutical services.

The firm was founded in 2006 by David Porter, who serves as the Founding Partner. Porter's vision was to establish an investment platform exclusively dedicated to the unique landscape and growth potential of the European healthcare market. This specialized focus was born from the understanding of a consistent demand for both capital and strategic guidance within the region's fragmented healthcare SME sector, with Sam Gray also holding a key leadership position as a Managing Partner.

Apposite Capital's client base consists of ambitious and expanding European SME businesses spanning the diverse healthcare ecosystem. The company's overarching mission is to facilitate improved healthcare access and quality for more individuals. This objective is pursued through a concentrated effort on three primary impact goals: enhancing the quality of healthcare delivery, broadening access to critical services, and fostering innovation across the sector, with an aim to deliver a positive, measurable health impact.